Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature
Marta Peri,1 Nicola Fazio2 1Medical Oncology, Department of Surgical, Oncological and Stomatological Sciences, University of Palermo, Palermo, Italy; 2Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, ItalyCorrespondence: Nico...
Guardado en:
Autores principales: | Peri M, Fazio N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a5ffe49e6b4458080b83ed597982c1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
por: Yoon MS
Publicado: (2020) -
Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury
por: Wang Xiaoping, et al.
Publicado: (2016) -
Prevalence of Neuroendocrine Tumors in the Gastrointestinal and Hepatobiliary Systems
por: Modesto J Varas Lorenzo, et al.
Publicado: (2019) -
Síndrome carcinoide y compromiso valvular cardíaco
por: Paredes,Alejandro, et al.
Publicado: (2014) -
Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer’s disease rats
por: Wang Xu, et al.
Publicado: (2016)